Sepsis (Blood Poisoning): Symptoms, Diagnosis, and Treatment – Saving Lives

What is Sepsis (Blood Poisoning)?

Sepsis is not simply an infection, but a complex clinical syndrome that occurs when the body's immune system malfunctions in response to an infection, causing damage to its own tissues and organs [4, 7]. Instead of effectively fighting the pathogen, the body triggers an excessive or, conversely, insufficient inflammatory response [6]. This dysregulated response is characterized by both hyperactivity and relative immunosuppression [6]. As a result, physiological and biological abnormalities occur that can lead to multiple organ failure [4, 7]. If sepsis progresses to septic shock, this condition is associated with very high mortality, which underscores the critical importance of early detection and treatment [7].

Causes and Risk Factors

Sepsis can develop from any infection – bacterial, viral, fungal, or parasitic [4, 7]. An initially localized infection, such as pneumonia, a urinary tract infection, or even a cut, can lead to a systemic inflammatory response.

A special risk group includes patients with comorbid conditions that alter their susceptibility to infections and their response to them [4]. Such conditions include liver cirrhosis, end-stage renal disease, and obesity [4]. In these patients, the usual signs of infection or sepsis may be masked due to their underlying disease or medications they are taking, making timely diagnosis difficult [4].

Pregnancy and the postpartum period also introduce physiological, hematological, and biochemical changes that can complicate the recognition of sepsis. Medical professionals must be exceptionally vigilant for subtle deviations from normal parameters in such patients [4].

Symptoms and Signs of Sepsis

Symptoms of sepsis can be nonspecific and progress rapidly. They reflect the body's inflammatory response at the cellular and systemic levels [4]. Common signs to look out for include:

• High body temperature or, conversely, low temperature (hypothermia).
• Rapid heart rate (tachycardia).
• Rapid breathing (tachypnea).
• Altered mental state, confusion, or disorientation.
• Chills and shivering.
• Weakness, malaise.
• Pale or mottled skin.
• Low blood pressure (hypotension).

Laboratory tests may show changes characteristic of inflammation. For example, patients with severe infection-related epilepsy syndromes, which are a manifestation of a pronounced inflammatory response, have been found to have elevated blood levels of interleukin-6 (IL-6) [1]. This underscores the role of inflammatory markers in diagnosis and condition monitoring.

It is important to remember that in patients with comorbidities or in special states (e.g., pregnancy), baseline vital signs may be altered, and chronic medications can mask key signs of disease severity [4]. This requires physicians to be extra attentive and capable of detecting even minor deviations from the norm [4].

Diagnosing Sepsis: The Key to Survival

Early and accurate diagnosis of sepsis is the cornerstone of successful treatment [7]. Because sepsis is a dynamic and heterogeneous disease [6], recognizing it can be challenging.

Diagnosis is based on a combination of clinical signs, physical examination data, and laboratory tests. Physicians assess physiological changes such as body temperature, heart rate, respiratory rate, and blood pressure, and look for signs of infection.

Laboratory tests include a complete blood count (to assess leukocytes, platelets), a comprehensive metabolic panel (to assess organ function, such as kidneys and liver), and inflammatory markers such as C-reactive protein and procalcitonin. New biomarkers are being developed and studied that can improve the recognition of sepsis, help monitor treatment response, and stratify patients by prognosis or biological response [6].

Additional studies, such as blood, urine, or sputum cultures, chest X-rays, ultrasounds, or CT scans, may be required to identify the source of the infection.

Modern Approaches to Sepsis Treatment

Treating sepsis requires an immediate and comprehensive approach. Every minute counts, as a delay in initiating therapy significantly worsens the prognosis [7].

The main principles of treatment include:

• Source Control: This is a paramount task [7]. It may include draining abscesses, removing infected tissues or devices (such as catheters), and surgical intervention to eliminate the source of infection (e.g., for appendicitis or bowel perforation).
• Broad-Spectrum Antibiotic Therapy: Immediate intravenous administration of antibiotics covering the most likely pathogens is critically important [7]. Once culture results and pathogen sensitivities are obtained, antibiotics can be adjusted to a more specific regimen.
• Supportive Therapy: Includes intravenous fluid administration to maintain blood pressure and organ perfusion, as well as cardiopulmonary support [7]. In some cases, vasopressor support to increase blood pressure, mechanical ventilation for respiratory failure, or dialysis for kidney failure may be required.

In addition to standard therapy, new approaches aimed at modulating the immune response are actively being investigated. For example, in cases of severe infection-related epilepsy syndromes where elevated levels of the inflammatory cytokine IL-6 are observed, tocilizumab—a drug that blocks IL-6 receptors—has been used [1]. In one described case of a child who received tocilizumab early in the disease course, there was a complete absence of seizures over a six-month follow-up period, whereas in another patient who received the drug later, the effect was less pronounced [1]. This demonstrates the potential of immunomodulatory therapy, especially when applied early, although sepsis remains a complex and heterogeneous disease requiring a personalized approach [6].

Sources

1. Case Report: Tocilizumab in Pediatric Febrile Infection-Related Epilepsy Syndrome. https://pubmed.ncbi.nlm.nih.gov/42317346/
2. Gastric Antral Vascular Ectasia as an Unusual Cause of Iron Deficiency Anemia in Primary Sjögren's Syndrome. https://pubmed.ncbi.nlm.nih.gov/42699858/
3. Plasma Cell Leukemia and Hyperviscosity Syndrome. https://pubmed.ncbi.nlm.nih.gov/2196691/
4. Sepsis in Special Populations. https://pubmed.ncbi.nlm.nih.gov/27908330/
5. Rare and Unusual Bleeding Manifestations in Congenital Coagulation Disorders: An Annotated Review. https://pubmed.ncbi.nlm.nih.gov/21873355/
6. Novel Biomarkers of Infection and Sepsis: Will They Change Current Clinical Practice? https://pubmed.ncbi.nlm.nih.gov/27533847/
7. Sepsis and Common Infections in Interventional Radiology. https://pubmed.ncbi.nlm.nih.gov/40634049/
8. Carbamazepine-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis with Severe Ocular and Oral Involvement: A Pediatric Case from Uganda. https://pubmed.ncbi.nlm.nih.gov/42698768/

The information provided in this article is for reference purposes only and cannot replace professional medical advice. Seek medical attention immediately if you experience symptoms of sepsis.